Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first ...

Autolus Therapeutics, a commercial-stage biopharmaceutical company, has announced plans to assess the feasibility of Cellares ...

Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled "A ...

As more customers seek one-stop shopping for their metal fabrications, more job shops are adding machining capabilities.

Shops with the ability to deliver small-batch runs, advanced materials and rapid prototyping send a strong signal to ...

Fictiv combines AI tools with precision welding and assembly to cut prototype-to-production time for complex manufacturing ...

The global Pharmaceutical Isolator market was valued at USD 432 Million in the year 2024 and is projected to reach a revised size of USD 509 Million by 2031, growing at a CAGR of 2.4% during the ...

Steakholder Foods ( ($STKH) ) has provided an update. On January 5, 2026, Steakholder Foods announced that its wholly owned subsidiary Twine ...

As the international community converges for the latest cycle of the China Import and Export Fair, famously known as the Canton Fair, the strategic focus on authentic East Asian condiments has reached ...